APA (7th ed.) Citation

P, O., C, D., V, M., M, A., X, D., A, S., . . . LB, R. (2023). The D-amino acid oxidase inhibitor luvadaxistat improves mismatch negativity in patients with schizophrenia in a randomized trial. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 48(7), 1052. https://doi.org/10.1038/s41386-023-01560-0

Chicago Style (17th ed.) Citation

P, O'Donnell, et al. "The D-amino Acid Oxidase Inhibitor Luvadaxistat Improves Mismatch Negativity in Patients with Schizophrenia in a Randomized Trial." Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology 48, no. 7 (2023): 1052. https://doi.org/10.1038/s41386-023-01560-0.

MLA (9th ed.) Citation

P, O'Donnell, et al. "The D-amino Acid Oxidase Inhibitor Luvadaxistat Improves Mismatch Negativity in Patients with Schizophrenia in a Randomized Trial." Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology, vol. 48, no. 7, 2023, p. 1052, https://doi.org/10.1038/s41386-023-01560-0.